165 related articles for article (PubMed ID: 34611413)
1. MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction].
Onco Targets Ther; 2021; 14():4937-4938. PubMed ID: 34611413
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction].
Onco Targets Ther; 2021; 14():4961-4962. PubMed ID: 34675537
[TBL] [Abstract][Full Text] [Related]
3. microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction].
Onco Targets Ther; 2021; 14():4739-4740. PubMed ID: 34526778
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway.
Lv Z; Ma J; Wang J; Lu J
Onco Targets Ther; 2019; 12():8501-8513. PubMed ID: 31686864
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-618 Directly Targets Metadherin mRNA to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output [Retraction].
Onco Targets Ther; 2021; 14():4963-4964. PubMed ID: 34629879
[TBL] [Abstract][Full Text] [Related]
6. microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction].
Cancer Manag Res; 2021; 13():4765. PubMed ID: 34163251
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression by Targeting PDK1/PI3K/AKT Pathway [Retraction].
Onco Targets Ther; 2023; 16():1023-1024. PubMed ID: 38090112
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-675 Directly Targets MAPK1 to Suppress the Oncogenicity of Papillary Thyroid Cancer and is Sponged by Long Non-Coding RNA RMRP [Retraction].
Onco Targets Ther; 2021; 14():4995-4996. PubMed ID: 34675540
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200b Acts as a Tumor Suppressor in Osteosarcoma via Targeting ZEB1 [Retraction].
Onco Targets Ther; 2021; 14():4637-4638. PubMed ID: 34511931
[TBL] [Abstract][Full Text] [Related]
10. Silencing of Long Non-Coding RNA-HCG18 Inhibits the Tumorigenesis of Gastric Cancer Through Blocking PI3K/Akt Pathway [Retraction].
Onco Targets Ther; 2020; 13():12195. PubMed ID: 33273823
[TBL] [Abstract][Full Text] [Related]
11. GATA1 Gene Silencing Inhibits Invasion, Proliferation and Migration of Cholangiocarcinoma Stem Cells via Disrupting the PI3K/AKT Pathway [Retraction].
Onco Targets Ther; 2021; 14():1005. PubMed ID: 33603406
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-652 Suppresses Malignant Phenotypes in Glioblastoma Multiforme via FOXK1-Mediated AKT/mTOR Signaling Pathway [Retraction].
Onco Targets Ther; 2021; 14():4935-4936. PubMed ID: 34611412
[TBL] [Abstract][Full Text] [Related]
13. MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-Mediated PI3K/Akt Signaling Pathway [Retraction].
Onco Targets Ther; 2021; 14():1859. PubMed ID: 33732003
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-145 Inhibits the Activation of the mTOR Signaling Pathway to Suppress the Proliferation and Invasion of Invasive Pituitary Adenoma Cells by Targeting AKT3 in vivo and in vitro [Retraction].
Onco Targets Ther; 2020; 13():6851. PubMed ID: 32764974
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Fibrous Sheath Interacting Protein 1 Expression Reduces Bladder Urothelial Carcinoma Cell Proliferation and Induces Apoptosis via Inhibition of the PI3K/AKT Pathway [Retraction].
Onco Targets Ther; 2022; 15():85-86. PubMed ID: 35087278
[TBL] [Abstract][Full Text] [Related]
16. Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells [Retraction].
Onco Targets Ther; 2022; 15():1039-1040. PubMed ID: 36176731
[TBL] [Abstract][Full Text] [Related]
17. Kanglaite Reverses Multidrug Resistance of HCC by Inducing Apoptosis and Cell Cycle Arrest via PI3K/AKT Pathway [Retraction].
Onco Targets Ther; 2024; 17():99-100. PubMed ID: 38371878
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-939 Directly Targets
Onco Targets Ther; 2021; 14():5001-5002. PubMed ID: 34675543
[TBL] [Abstract][Full Text] [Related]
19. LINC00958 Promotes the Malignancy of Nasopharyngeal Carcinoma by Sponging microRNA-625 and Thus Upregulating NUAK1 [Retraction].
Onco Targets Ther; 2023; 16():329-330. PubMed ID: 37261081
[TBL] [Abstract][Full Text] [Related]
20. Antitumor Effect of Triptolide in T-Cell Lymphoblastic Lymphoma by Inhibiting Cell Viability, Invasion, and Epithelial-Mesenchymal Transition via Regulating the PI3K/AKT/mTOR Pathway [Retraction].
Onco Targets Ther; 2024; 17():303-304. PubMed ID: 38595926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
